Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Repeat VTE risk heightened in HIV patients

Publish date:: March 15, 2019

Key clinical point: VTE risk factors look unique to HIV.

Major finding: HIV-positive patients were at a 67% increased risk of repeat VTE in the first year after stopping anticoagulant therapy.

Study details: Retrospective analysis of repeat VTE (n = 4,158). Retrospective analysis of first-time VTE (n = 357).

Disclosures: The first-time VTE study was funded by the National Institutes of Health. The repeat VTE study was funded by the Dutch government. Dr. Crane and Dr. Reiss have no conflicts of interest.

Citation:

Rokx C et al. CROI 2019, Abstract 636; and Tenforde MW et al. CROI 2019, Abstract 637.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Hematology

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,